ResMed | RMD - Interest Expense On Debt

Stock Price
201.88
Daily Change
-0.58 -0.29%
Monthly
-10.16%
Yearly
-19.79%
Q2 Forecast
202.48

ResMed reported $8.79M in Interest Expense on Debt for its fiscal quarter ending in September of 2025.





Interest Expense On Debt Change Date
Ansell USD 20.6M 300K Dec/2025
Artivion USD 5.53M 589K Dec/2025
AtriCure USD 1.37M 42K Dec/2025
Baxter International USD 58M 14M Sep/2025
Cochlear AUD 6.3M 3.65M Dec/2025
Cooper Companies USD 22.4M 2M Dec/2025
CSL USD 215M 111M Dec/2025
Dexcom USD 4.2M 500K Dec/2025
Edwards Lifesciences USD 35.9M 2.7M Dec/2025
Fisher Paykel Healthcare NZD 5.5M 700K Dec/2025
Globus Medical USD 5.44B 5.44B Mar/2026
Haemonetics USD 7.4M 190K Dec/2025
Idexx Laboratories USD 7.74M 2.34M Mar/2026
Inogen 1.03M 384K Mar/2025
Insulet USD 14.7M 5.5M Mar/2026
Integra LifeSciences USD 22.46M 1.21M Mar/2026
Intuitive Surgical USD 20.11B 58.39B Mar/2026
Masimo USD 6.1M 1.4M Mar/2026
Medtronic USD 181M 0 Dec/2025
Philips EUR 83M 26M Mar/2026
Ramsay Health Care AUD 300.6M 15.5M Dec/2025
ResMed USD 8.79M 14.55M Sep/2025
Sigma Healthcare AUD 7.97M 365K Jan/2024
Sonic Healthcare AUD 86.91M 43.94M Dec/2024
Steris USD 14.9M 0 Dec/2025
Teleflex USD 25.72M 2.43M Mar/2026
Thermo Fisher Scientific USD 354M 11M Mar/2026